Fatty liver has a new name and a new drug
If you’ve never heard of NAFLD (Non-alcoholic Fatty Liver Disease), or MASLD (Metabolic dysfunction-Associated Steatotic Liver disease (MASLD), its equally non-catchy new name[1], you’re not alone. Yet this condition affects 30% of the global population. Image: DALL-e As an anesthesiologist working in the operating rooms of a large university medical center in Cleveland, Ohio …
